Skip to main content
. 2016 Sep 21;4:179–185. doi: 10.1016/j.conctc.2016.09.005

Fig. 1.

Fig. 1

Response Profiles for 10 Survey Questions. Inform (Q3), Privacy (Q9), Safety (Q10), SLT (Second Line Treatment, Q6), Altruism (Q7), IE (Increased Effort, Q8), Phase I (Q2), DC (Drug Companies, Q1), FTO (First Treatment Option, Q5), RT (Randomized Trial, Q4). The responses of first three questions are significant different from the last three (Inform & RT: p < 0.0001, Privacy & FTO: p < 0.0001, Safety & DC: p = 0.0299).